ArticleEuropean journal of pediatrics2026

Real-world impact of nirsevimab on the epidemiology and severity of pediatric respiratory syncytial virus infections: a three-season cohort study in Italy.

Alessandra Chiara Ferrari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.